ATS 2018 International Conference

The Impact of Exacerbation Definition in Non-Cystic Fibrosis Bronchiectasis (NCFB) Studies: Results from the RESPIRE Trials of Ciprofloxacin Dry Powder for Inhalation (DPI) Using Different Definitions of Exacerbation [Board No. 622]

Location: Board no. 622

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Wednesday

May

9:15 AM

11:15 AM

Speaker(s)/Author(s)

Robert Wilson

MD
Royal Brompton Hospital

Kevin Winthrop

MD, MPH
OHSU Division of Infectious Diseases;OHSU School of Medicine;OHSU-PSU School of Public Health;Oregon Health & Science University;Oregon Health and Science University;Oregon Health and Sciences Uni

Tiemo Joerg Bandel

MD
Bayer AG

Elisabeth Operschall

MD
Bayer AG

Timothy R. Aksamit

MD
Mayo Clinic

Stuart Elborn

MD
Queens University;Royal Brompton Hospital

Anthony De Soyza

MBBS, PhD
Freeman Hospital;Newcastle University;Newcastle University & Freeman Hospital;University of Newcastle

View Abstract

The Impact of Exacerbation Definition in Non-Cystic Fibrosis Bronchiectasis (NCFB) Studies: Results from the RESPIRE Trials of Ciprofloxacin Dry Powder for Inhalation (DPI) Using Different Definitions of Exacerbation

Parent Sessions

D23 - ADULT CF AND NON-CF BRONCHIECTASIS...
05-23-2018 9:15 AM - 11:15 AM

Event